The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis.
<h4>Background</h4>This review and meta-analysis aimed to systematically evaluate the clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C (MMC) in patients with nonmuscular invasive bladder cancer (NMIBC) after transurethral resection of bladder tu...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0276453&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849683061248098304 |
|---|---|
| author | Weijian Zhou Jianping Liu Dongdong Mao Changying Hu Dianjun Gao |
| author_facet | Weijian Zhou Jianping Liu Dongdong Mao Changying Hu Dianjun Gao |
| author_sort | Weijian Zhou |
| collection | DOAJ |
| description | <h4>Background</h4>This review and meta-analysis aimed to systematically evaluate the clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C (MMC) in patients with nonmuscular invasive bladder cancer (NMIBC) after transurethral resection of bladder tumour (TURBT).<h4>Methods</h4>The Embase, PubMed, CNKI, CBM, WANGFANG, VIP, Cochrane Library, and Clinicaltrial.com databases were searched for articles published before April 2022. The experimental group was treated with intravesical instillation of MMC assisted by equipment, including radiofrequency-induced thermochemotherapy, conductive thermochemical therapy, electromotive drug administration, or locoregional hyperthermia. The control group was treated with simple MMC perfusion. The outcomes of interest in the meta-analysis were recurrence, progression, side-effects, gross haematuria, and bladder irritation.<h4>Results</h4>A total of 15 studies that enrolled 1,190 patients were included in the meta-analysis. Compared to that of the control group, device-assisted intravesical instillation of MMC significantly reduced both tumour recurrence (odds ratio [OR] = 0.32, 95% confidence interval [CI] [0.24, 0.42], P <0.00001) and progression (OR = 0.29, 95% CI [0.12, 0.67], P = 0.004). There were no significant differences between the two groups in terms of safety (OR = 1.21, 95% CI [0.66,2.21], P = 0.54), bladder irritation (OR = 1.06, 95% CI [0.72,1.55], P = 0.78), or gross haematuria (OR = 1.11, 95% CI [0.64,1.94], P = 0.72).<h4>Conclusions</h4>Equipment-assisted intravesical instillation of MMC significantly reduced the recurrence and progression of patients with NMIBC who underwent TURBT and improved their quality of life. Given the significant heterogeneity in research quality and sample size among earlier studies, more prospective, multicentre, large sample randomized controlled trials are needed to supplement and verify this in the future. |
| format | Article |
| id | doaj-art-e6dfd860d88c4534b2e1935bc399e73a |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-e6dfd860d88c4534b2e1935bc399e73a2025-08-20T03:24:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-011710e027645310.1371/journal.pone.0276453The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis.Weijian ZhouJianping LiuDongdong MaoChangying HuDianjun Gao<h4>Background</h4>This review and meta-analysis aimed to systematically evaluate the clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C (MMC) in patients with nonmuscular invasive bladder cancer (NMIBC) after transurethral resection of bladder tumour (TURBT).<h4>Methods</h4>The Embase, PubMed, CNKI, CBM, WANGFANG, VIP, Cochrane Library, and Clinicaltrial.com databases were searched for articles published before April 2022. The experimental group was treated with intravesical instillation of MMC assisted by equipment, including radiofrequency-induced thermochemotherapy, conductive thermochemical therapy, electromotive drug administration, or locoregional hyperthermia. The control group was treated with simple MMC perfusion. The outcomes of interest in the meta-analysis were recurrence, progression, side-effects, gross haematuria, and bladder irritation.<h4>Results</h4>A total of 15 studies that enrolled 1,190 patients were included in the meta-analysis. Compared to that of the control group, device-assisted intravesical instillation of MMC significantly reduced both tumour recurrence (odds ratio [OR] = 0.32, 95% confidence interval [CI] [0.24, 0.42], P <0.00001) and progression (OR = 0.29, 95% CI [0.12, 0.67], P = 0.004). There were no significant differences between the two groups in terms of safety (OR = 1.21, 95% CI [0.66,2.21], P = 0.54), bladder irritation (OR = 1.06, 95% CI [0.72,1.55], P = 0.78), or gross haematuria (OR = 1.11, 95% CI [0.64,1.94], P = 0.72).<h4>Conclusions</h4>Equipment-assisted intravesical instillation of MMC significantly reduced the recurrence and progression of patients with NMIBC who underwent TURBT and improved their quality of life. Given the significant heterogeneity in research quality and sample size among earlier studies, more prospective, multicentre, large sample randomized controlled trials are needed to supplement and verify this in the future.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0276453&type=printable |
| spellingShingle | Weijian Zhou Jianping Liu Dongdong Mao Changying Hu Dianjun Gao The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis. PLoS ONE |
| title | The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis. |
| title_full | The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis. |
| title_fullStr | The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis. |
| title_full_unstemmed | The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis. |
| title_short | The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis. |
| title_sort | clinical efficacy and safety of equipment assisted intravesical instillation of mitomycin c after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer a meta analysis |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0276453&type=printable |
| work_keys_str_mv | AT weijianzhou theclinicalefficacyandsafetyofequipmentassistedintravesicalinstillationofmitomycincaftertransurethralresectionofbladdertumourinpatientswithnonmuscularinvasivebladdercancerametaanalysis AT jianpingliu theclinicalefficacyandsafetyofequipmentassistedintravesicalinstillationofmitomycincaftertransurethralresectionofbladdertumourinpatientswithnonmuscularinvasivebladdercancerametaanalysis AT dongdongmao theclinicalefficacyandsafetyofequipmentassistedintravesicalinstillationofmitomycincaftertransurethralresectionofbladdertumourinpatientswithnonmuscularinvasivebladdercancerametaanalysis AT changyinghu theclinicalefficacyandsafetyofequipmentassistedintravesicalinstillationofmitomycincaftertransurethralresectionofbladdertumourinpatientswithnonmuscularinvasivebladdercancerametaanalysis AT dianjungao theclinicalefficacyandsafetyofequipmentassistedintravesicalinstillationofmitomycincaftertransurethralresectionofbladdertumourinpatientswithnonmuscularinvasivebladdercancerametaanalysis AT weijianzhou clinicalefficacyandsafetyofequipmentassistedintravesicalinstillationofmitomycincaftertransurethralresectionofbladdertumourinpatientswithnonmuscularinvasivebladdercancerametaanalysis AT jianpingliu clinicalefficacyandsafetyofequipmentassistedintravesicalinstillationofmitomycincaftertransurethralresectionofbladdertumourinpatientswithnonmuscularinvasivebladdercancerametaanalysis AT dongdongmao clinicalefficacyandsafetyofequipmentassistedintravesicalinstillationofmitomycincaftertransurethralresectionofbladdertumourinpatientswithnonmuscularinvasivebladdercancerametaanalysis AT changyinghu clinicalefficacyandsafetyofequipmentassistedintravesicalinstillationofmitomycincaftertransurethralresectionofbladdertumourinpatientswithnonmuscularinvasivebladdercancerametaanalysis AT dianjungao clinicalefficacyandsafetyofequipmentassistedintravesicalinstillationofmitomycincaftertransurethralresectionofbladdertumourinpatientswithnonmuscularinvasivebladdercancerametaanalysis |